Assets Changement Date
Abbott USD 73.35B 440M 2023-06
Agilent USD 10.95B 185M 2023-12
Becton, Dickinson and Co. USD 52.27B 506M 2023-12
Bio Techne USD 2.73B 24.61M 2023-12
Bio-Rad Laboratories USD 12.3B 403.13M 2023-12
Boston Scientific USD 34.04B 442M 2023-09
Bruker USD 4.24B 419.2M 2023-12
Catalent USD 9.99B 35M 2023-12
Charles River Laboratories USD 8.2B 587.99M 2023-12
Cooper Companies USD 12.03B 373.7M 2023-12
Danaher USD 84.49B 3.25B 2023-12
Dexcom USD 6.26B 331.7M 2023-12
Edwards Lifesciences USD 9.36B 7.6M 2023-12
Exact Sciences USD 6.47B 50.5M 2023-12
Fuji Electric JPY 1.17T 40.34B 2023-09
Fujifilm JPY 4.53T 152.38B 2023-09
General Electric USD 163.05B 6.38B 2023-12
Globus Medical USD 5.09B 269.79M 2023-12
Hologic USD 8.47B 669.8M 2023-12
Illumina USD 10.11B 11M 2023-12
Insulet USD 2.59B 120.5M 2023-12
Integra LifeSciences USD 3.78B 42.62M 2023-12
Intuitive Surgical USD 15.44B 728.8M 2023-12
IQVIA Holdings USD 26.68B 704M 2023-12
Mettler Toledo International USD 3.36B 66.82M 2023-12
OraSure Technologies USD 458.43M 4.84M 2023-09
Quidel USD 8.56B 24M 2023-12
Revvity USD 13.56B 143.12M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Siemens EUR 145.07B 1.38B 2023-09
Stryker USD 39.88B 1.84B 2023-12
Teleflex USD 7.53B 38.91M 2023-12
Thermo Fisher Scientific USD 98.73B 1.67B 2023-12
Waters USD 4.5B 51.02M 2023-09
Zimmer Biomet Holdings USD 21.5B 279.6M 2023-12



Hologic Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.